Cover Image

Resveratrol delays the progression of diabetic nephropathy through multiple pathways: A dose–response meta‐analysis based on animal models

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xiaojing Liu, Xia Gu, Jiao Zhang, Xiangmeng Li, Xiansen Wei, Shimin Jiang, Wenge Li
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Smoking and diabetic nephropathy: An updated systematic review and meta‐analysis
by: Haihui Zhu, et al.
Published: (2024)

Cordycepin ameliorates diabetic nephropathy injury by activating the SLC7A11/GPX4 pathway
by: Bing Wu, et al.
Published: (2025)

Association between early‐stage diabetic nephropathy and the delayed monophasic glucose peak during oral glucose tolerance test in type 2 diabetes mellitus
by: Han Zhang, et al.
Published: (2024)

Letter to the Editor in response to the article “Dysregulation of miR ‐21‐5p in diabetic nephropathy and its role in inflammatory response”
by: Ciyu Zhao
Published: (2026)

Construction of a metabolic‐immune model for predicting the risk of diabetic nephropathy and study of gut microbiota
by: Mengting Dai, et al.
Published: (2025)

Calebin A mitigates oxidative stress and inflammation in diabetic nephropathy via Nrf2/ HO ‐1 and NF ‐ κB signaling pathways
by: Reyhane Ghayour Vatanparast, et al.
Published: (2026)

Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis
by: Kang Li, et al.
Published: (2025)

Methodological and statistical considerations on calebin A‐mediated nephroprotection in diabetic nephropathy
by: Yindan Song, et al.
Published: (2026)

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity‐responsive enhancer‐binding protein expression to alleviate diabetic nephropathy
by: Qibo Hu, et al.
Published: (2024)

O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
by: Bingxue Qi, et al.
Published: (2024)

Clinical significance of renal histological diagnosis in patients with type 2 diabetes and proteinuria atypical for diabetic nephropathy
by: Shogo Kuwagata, et al.
Published: (2026)

Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies
by: Reza Amani‐Beni, et al.
Published: (2026)

Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score
by: Lin Ning, et al.
Published: (2026)

A Mendelian randomization study on the causal association of circulating cytokines with diabetic nephropathy
by: Yiming Xu, et al.
Published: (2025)

Testing methods used to predict disease progression in children with early‐stage type 1 diabetes: A systematic review and meta‐analysis
by: Rabbi Swaby, et al.
Published: (2025)

Fully automated insulin delivery systems in type 1 diabetes: A systematic review and meta‐analysis
by: Wenqi Fan, et al.
Published: (2025)

Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification
by: Shahad W. Kattan, et al.
Published: (2025)

Mechanisms of hesperetin in alleviating diabetic nephropathy: Network pharmacology, molecular docking, and experimental validation
by: Yiwen Guo, et al.
Published: (2026)

Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
by: Keiko Maruyama‐Sakurai, et al.
Published: (2024)

Effect of administration and withdrawal of the sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, on renal protection in individuals with type 2 diabetes mellitus and diabetic nephropathy: A multicenter, single‐arm study (RESTORE‐nephropathy study)
by: Ayako Shigeta, et al.
Published: (2025)

Hydrogel dressings for diabetic foot ulcer: A systematic review and meta‐analysis
by: Hongjiao Zhao, et al.
Published: (2024)

Wnt inhibitory factor 1 inhibits glycolysis through the HIF1α / PFKFB3 signalling pathway to regulate macrophage polarization and alleviate diabetic retinopathy
by: Meng‐Jiao Wang, et al.
Published: (2026)

Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy
by: Yidong Zhu, et al.
Published: (2024)

The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy
by: Merve Çatak, et al.
Published: (2025)

LncRNA VCAN‐AS1 serves as a diagnostic biomarker and drives pathogenesis in diabetic nephropathy via the miR‐205‐5p/VEGFA axis
by: Jing Zhou, et al.
Published: (2026)

Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual‐like protein 1 and acyl‐coenzyme A synthetase long‐chain family member 4 signaling pathway
by: Shuai Zhu, et al.
Published: (2024)

Long‐acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population‐based cohort study
by: Julia Brillinger, et al.
Published: (2026)

Association of the IL‐6R rs2228145 polymorphism with diabetic nephropathy: A case‐control study
by: Pavla Izakovicova, et al.
Published: (2025)

Impact of lifestyle on diabetic nephropathy in aged 18–64 years: A population‐based cross‐sectional analysis from NHANES 2007–2018
by: Zhijun Zhang, et al.
Published: (2025)

Druggable targets and immunological mechanisms for type 1 diabetes treatment: Genetic evidence from multi‐omics Mendelian randomization combined with meta‐analysis
by: Xianghui Mei, et al.
Published: (2025)

Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes
by: Resham Lal Gurung, et al.
Published: (2025)

A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
by: Jiewen Guan, et al.
Published: (2025)

Optical coherence tomography angiography for detection of microvascular changes in early diabetes: A systematic review and meta‐analysis
by: Fan Yang, et al.
Published: (2024)

Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A meta‐analysis
by: Jie Gong, et al.
Published: (2024)

MiR‐10a‐5p aggravates podocyte injury in diabetic nephropathy by inhibiting E2f7‐mediated autophagy
by: Wulin Tong, et al.
Published: (2026)

Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease
by: Jiawei Geng, et al.
Published: (2024)

Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls
by: Yu Yuan, et al.
Published: (2024)

The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: A systematic review and meta‐analysis
by: Rebecca A. Dennison, et al.
Published: (2024)

The protective role of TIGIT + B cells in attenuating type 1 diabetes progression
by: Yiman Peng, et al.
Published: (2025)

Impact of bariatric surgery on glycaemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: A meta‐analysis
by: Xu Han, et al.
Published: (2025)